These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24235937)

  • 1. The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.
    Gedik H; Yildirmak T; Simsek F; Kanturk A; Aydýn D; Anca D; Yokus O; Demirel N
    Afr Health Sci; 2013 Jun; 13(2):362-8. PubMed ID: 24235937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.
    Gedik H; Şimşek F; Kantürk A; Yıldırmak T; Arıca D; Aydın D; Yokuş O; Demirel N
    Afr Health Sci; 2014 Dec; 14(4):899-905. PubMed ID: 25834499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies.
    Gedik H; Yıldırmak T; Simşek F; Kantürk A; Arıca D; Aydın D; Yokuş O; Demirel N; Arabacı C
    J Infect Dev Ctries; 2014 Sep; 8(9):1113-8. PubMed ID: 25212075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Stewardship in a Hematological Malignancy Unit: Carbapenem Reduction and Decreased Vancomycin-Resistant Enterococcus Infection.
    Webb BJ; Majers J; Healy R; Jones PB; Butler AM; Snow G; Forsyth S; Lopansri BK; Ford CD; Hoda D
    Clin Infect Dis; 2020 Aug; 71(4):960-967. PubMed ID: 31751470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
    Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
    Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
    Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
    Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.
    Cho SY; Lee DG; Choi SM; Kwon JC; Kim SH; Choi JK; Park SH; Park YJ; Choi JH; Yoo JH
    BMC Infect Dis; 2013 Oct; 13():504. PubMed ID: 24164924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
    Webb BJ; Healy R; Majers J; Burr Z; Gazdik M; Lopansri B; Hoda D; Petersen FB; Ford C
    Clin Infect Dis; 2017 Jun; 64(12):1753-1759. PubMed ID: 28369204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study.
    Kömürcü B; Tükenmez Tigen E; Toptaş T; Fıratlı Tuğlular T; Korten V
    Expert Rev Hematol; 2020 Aug; 13(8):923-927. PubMed ID: 32574123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which Multidrug-Resitant Bacteria are Emerging in Patients with Hematological Malignancies?: One-Year Report.
    Gedik H; Şimşek F; Yıldırmak T; Kantürk A; Aydın D; Demirel N; Yokuş O; Arıca D
    Indian J Hematol Blood Transfus; 2015 Mar; 31(1):51-6. PubMed ID: 25548445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
    Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
    Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogammaglobulinemia and Poor Performance Status are Predisposing Factors for Vancomycin-Resistant Enterococcus Colonization in Patients with Hematological Malignancies.
    Ümit EG; Kuloğlu F; Demir AM
    Turk J Haematol; 2017 Mar; 34(1):89-92. PubMed ID: 27531123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance.
    Bae KS; Shin JA; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    Infection; 2019 Jun; 47(3):417-424. PubMed ID: 30565009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
    Bossaer JB; Hall PD; Garrett-Mayer E
    Support Care Cancer; 2010 Feb; 19(2):231-7. PubMed ID: 20069435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
    Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
    Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
    Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
    Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.
    Liss BJ; Vehreschild JJ; Cornely OA; Hallek M; Fätkenheuer G; Wisplinghoff H; Seifert H; Vehreschild MJ
    Infection; 2012 Dec; 40(6):613-9. PubMed ID: 22665143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bloodstream infections in patients with hematological malignancies: which is more fatal - cancer or resistant pathogens?
    Gedik H; Simşek F; Kantürk A; Yildirmak T; Arica D; Aydin D; Demirel N; Yokuş O
    Ther Clin Risk Manag; 2014; 10():743-52. PubMed ID: 25258539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.
    Almyroudis NG; Lesse AJ; Hahn T; Samonis G; Hazamy PA; Wongkittiroch K; Wang ES; McCarthy PL; Wetzler M; Segal BH
    Infect Control Hosp Epidemiol; 2011 May; 32(5):490-6. PubMed ID: 21515980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
    Khoo AL; Zhao YJ; Teng M; Ying D; Jin J; Chee YL; Poon LM; Lim SE; Koh LP; Chng WJ; Lim BP; Hsu LY; Chai LYA
    Int J Antimicrob Agents; 2018 Sep; 52(3):350-357. PubMed ID: 29751120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.